Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study

Overview of attention for article published in Lung Cancer (01695002), January 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 168 followers.

Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study. https://t.co/ZGX8f5qYBu

06 Mar 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.